Australia markets open in 3 hours 28 minutes

Allergy Therapeutics plc (AGY.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
19.75+0.75 (+3.95%)
At close: 02:16PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 122.36M
Enterprise value 90.90M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.63
Price/book (mrq)2.23
Enterprise value/revenue 1.15
Enterprise value/EBITDA 301.01

Trading information

Stock price history

Beta (5Y monthly) 1.44
52-week change 3-37.19%
S&P500 52-week change 3-6.69%
52-week high 340.50
52-week low 316.00
50-day moving average 320.02
200-day moving average 325.88

Share statistics

Avg vol (3-month) 334.6k
Avg vol (10-day) 325.44k
Shares outstanding 5644M
Implied shares outstanding 6N/A
Float 8350.7M
% held by insiders 184.49%
% held by institutions 16.75%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)31 Dec 2021


Profit margin -6.81%
Operating margin (ttm)-5.62%

Management effectiveness

Return on assets (ttm)-2.90%
Return on equity (ttm)-9.47%

Income statement

Revenue (ttm)79M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)-9.90%
Gross profit (ttm)62.23M
Net income avi to common (ttm)-5.38M
Diluted EPS (ttm)-0.80
Quarterly earnings growth (yoy)-55.30%

Balance sheet

Total cash (mrq)41.38M
Total cash per share (mrq)0.06
Total debt (mrq)9.93M
Total debt/equity (mrq)18.06
Current ratio (mrq)3.80
Book value per share (mrq)0.09

Cash flow statement

Operating cash flow (ttm)-1.03M
Levered free cash flow (ttm)-690k